| CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles D Beier, P Hau, M Proescholdt, A Lohmeier, J Wischhusen, PJ Oefner, ... Cancer research 67 (9), 4010-4015, 2007 | 1480 | 2007 |
| SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro … M Uhl, S Aulwurm, J Wischhusen, M Weiler, JY Ma, R Almirez, ... Cancer research 64 (21), 7954-7961, 2004 | 486 | 2004 |
| A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape H Wiendl, M Mitsdoerffer, V Hofmeister, J Wischhusen, A Bornemann, ... The Journal of Immunology 168 (9), 4772-4780, 2002 | 416 | 2002 |
| O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells M Hermisson, A Klumpp, W Wick, J Wischhusen, G Nagel, W Roos, ... Journal of neurochemistry 96 (3), 766-776, 2006 | 404 | 2006 |
| Temozolomide preferentially depletes cancer stem cells in glioblastoma D Beier, S Röhrl, DR Pillai, S Schwarz, LA Kunz-Schughart, P Leukel, ... Cancer research 68 (14), 5706-5715, 2008 | 396 | 2008 |
| Toward the blood-borne miRNome of human diseases A Keller, P Leidinger, A Bauer, A ElSharawy, J Haas, C Backes, ... Nature methods 8 (10), 841-843, 2011 | 392 | 2011 |
| RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates … MA Friese, J Wischhusen, W Wick, M Weiler, G Eisele, A Steinle, M Weller Cancer research 64 (20), 7596-7603, 2004 | 374 | 2004 |
| Growth/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint J Wischhusen, I Melero, WH Fridman Frontiers in Immunology 11, 542657, 2020 | 307 | 2020 |
| Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin C Lottaz, D Beier, K Meyer, P Kumar, A Hermann, J Schwarz, M Junker, ... Cancer research 70 (5), 2030-2040, 2010 | 307 | 2010 |
| TGF-β and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells G Eisele, J Wischhusen, M Mittelbronn, R Meyermann, I Waldhauer, ... Brain 129 (9), 2416-2425, 2006 | 286 | 2006 |
| Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma J Wischhusen, G Jung, I Radovanovic, C Beier, JP Steinbach, A Rimner, ... Cancer research 62 (9), 2592-2599, 2002 | 256 | 2002 |
| Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening SFM Häusler, A Keller, PA Chandran, K Ziegler, K Zipp, S Heuer, ... British journal of cancer 103 (5), 693-700, 2010 | 239 | 2010 |
| Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell … SFM Häusler, I Montalbán del Barrio, J Strohschein, P Anoop Chandran, ... Cancer Immunology, Immunotherapy 60, 1405-1418, 2011 | 213 | 2011 |
| A specific miRNA signature in the peripheral blood of glioblastoma patients P Roth, J Wischhusen, C Happold, PA Chandran, S Hofer, G Eisele, ... Journal of neurochemistry 118 (3), 449-457, 2011 | 208 | 2011 |
| Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D M Krockenberger, Y Dombrowski, C Weidler, M Ossadnik, A Hönig, ... The Journal of Immunology 180 (11), 7338-7348, 2008 | 197 | 2008 |
| Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? VS Bruttel, J Wischhusen Frontiers in immunology 5, 93350, 2014 | 195 | 2014 |
| GDF-15 contributes to proliferation and immune escape of malignant gliomas P Roth, M Junker, I Tritschler, M Mittelbronn, Y Dombrowski, SN Breit, ... Clinical cancer research 16 (15), 3851-3859, 2010 | 194 | 2010 |
| CD133 expression and cancer stem cells predict prognosis in high‐grade oligodendroglial tumors D Beier, J Wischhusen, W Dietmaier, P Hau, M Proescholdt, A Brawanski, ... Brain pathology 18 (3), 370-377, 2008 | 187 | 2008 |
| Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion SFM Häusler, IM Del Barrio, J Diessner, RG Stein, J Strohschein, A Hönig, ... American journal of translational research 6 (2), 129, 2014 | 177 | 2014 |
| Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer Q Gao, Z Yang, S Xu, X Li, X Yang, P Jin, Y Liu, X Zhou, T Zhang, C Gong, ... Journal of Experimental Medicine 216 (3), 688-703, 2019 | 173 | 2019 |
